Curative Biotechnology, Inc. (CUBT)
OTCMKTS · Delayed Price · Currency is USD
0.0077
-0.0022 (-22.38%)
Aug 22, 2025, 3:31 PM EDT
Curative Biotechnology Market Cap
Curative Biotechnology has a market cap or net worth of $10.05 million as of August 22, 2025. Its market cap has decreased by -27.30% in one year.
Market Cap
10.05M
Enterprise Value
12.94M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since February 22, 2008, Curative Biotechnology's market cap has decreased from 22.36M to 10.05M, a decrease of -55.06%. That is a compound annual growth rate of -4.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 10.05M | -14.62% |
| Dec 31, 2024 | 11.77M | -12.66% |
| Dec 29, 2023 | 13.47M | 17.84% |
| Dec 30, 2022 | 11.43M | -61.12% |
| Dec 31, 2021 | 29.41M | 201.64% |
| Dec 31, 2020 | 9.75M | 1,242.22% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 610.45M |
| Glass House Brands | 554.44M |
| Nika Pharmaceuticals | 453.04M |
| CytoDyn | 363.56M |
| Northwest Biotherapeutics | 355.76M |
| American Oncology Network | 355.44M |